Cyclophosphamide: Clinical Trials

2 trials for Cyclophosphamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Cyclophosphamide: new trials by email Literature Review of Cyclophosphamide trials Research Report on Cyclophosphamide

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
Cyclophosphamide, Mycophenolate Mofetil - Mycophenolate Mofetil, Cyclophosphamide
Phase 4UnknownSecond Xiangya Hospital of Central South University2242022-07-252022-08-10
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
Upfront autologous HSCT - Systemic Sclerosis, Systemic Scleroses, Diffuse
Phase 4CompletedUMC Utrecht602020-09-172026-03-24

Narrower conditions

Lupus Nephritis (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Autoimmune Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Skin Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Cyclophosphamide (1)  ·  Mycophenolic Acid (1)

Sponsors

Second Xiangya Hospital of Central South University (1)  ·  UMC Utrecht (1)

Countries

China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Jacob M van Laar, MD PhD (1)  ·  Julia Spierings (1)  ·  Xiaochuan Wu (1)

Results publications

PMID 33737437